A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

July 31, 2029

Conditions
Small Cell Lung Cancer
Interventions
DRUG

AK112

AK112 20mg/kg, intravenous \[IV\]),Q3W

OTHER

Placebo

Placebo, intravenous \[IV\]),Q3W

Trial Locations (42)

100142

Beijing Cancer Hospital, Beijing

100853

The First Medical Center of Chinese PLA General Hospital, Beijing

101149

Beijing Chest Hospital, Beijing

130000

Jilin Cancer Hospital, Changchun

150081

Harbin Medical University Cancer Hospital, Harbin

150086

The Second Affiliated Hospital of Harbin Medical University, Harbin

200030

Shanghai Chest Hospital, Shanghai

200433

Shanghai Pulmonary Hospital, Shanghai

221002

Xuzhou Municipal Hospital, Xuzhou

250021

Shandong Provincial Hospital, Jinan

250117

Shandong Cancer Hospital, Jinan

266000

Qingdao Central Hospital of Health and Rehabilitation Sciences University, Qingdao

276003

Linyi People's Hospital, Linyi

277100

Zaozhuang Municipal Hospital, Zaozhuang

300013

Shanxi Cancer Hospital, Taiyuan

300060

Tianjin Cancer Hospital, Tianjin

317000

Taizhou Hospital of Zhejiang Province, Taizhou

325000

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

330006

The First Affiliated Hospital of Nanchang University, Nanchang

341000

The First Affiliated Hospital of Gannan Medical University, Gannan

350014

Fujian Cancer Hospital, Fuzhou

363000

Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou

364000

Longyan First Hospital, Longyan

410013

Hunan Cancer Hospital, Changsha

Hunan Cancer Hospital, Changsha

434000

Jingzhou First People's Hospital, Jingzhou

450008

Henan Cancer Hospital, Zhengzhou

453100

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

455000

Anyang Cancer Hospital, Anyang

529030

Jiangmen Central Hospital, Jiangmen

530021

Affiliated Cancer Hospital of Guangxi Medical University, Nanning

The First Affiliated Hospital of Guangxi Medical University, Nanning

545006

Liuzhou People's Hospital, Liuzhou

563000

The Second Affiliated Hospital of Zunyi Medical University, Zunyi

610072

Sichuan People's Hospital, Chengdu

621000

Mianyang Central Hospital, Mianyang

650118

Yunnan Cancer Hospital, Kunming

Yunnan Cancer Hospital, Kunming

655000

Qujing First People's Hospital, Qujing

750004

Ningxia Medical University General Hospital, Yinchuan

050011

The Fourth Hospital of Hebei Medical University, Shijiazhuang

063001

Tangshan People's Hospital, Tangshan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Akeso

INDUSTRY